Willpower or Wellness? Mo’Nique’s Warning on GLP-1 Weight Loss Drugs By Phatabulous Magazine When Mo’Nique speaks, she doesn’t whisper. She testifies. The Oscar-winning actress and comedian recently shared her concerns about the growing popularity of GLP-1 weight-loss drugs, questioning whether we are sacrificing something deeper than pounds on the scale. “What is the long-term effects? What will it do to your body? Your mind? What will it do to us five years from now, 10 years from now?” she asked in a heartfelt video. “They’re taking away our willpower. They’re taking away our fight.” Her message wasn’t just about medication. It was about autonomy. About discipline. About self-trust. And for many in the plus-size community, her words landed heavy. GLP-1 medications like Ozempic, Wegovy, and Mounjaro were originally developed to treat type 2 diabetes. They mimic a hormone that regulates blood sugar and appetite, helping people feel full faster and longer. In recent years, they’ve beco...